Open Access

Change in the neutrophil‑to‑lymphocyte ratio during chemotherapy may predict prognosis in patients with advanced or metastatic colorectal cancer

  • Authors:
    • Tetsutaro Nemoto
    • Shungo Endo
    • Noriyuki Isohata
    • Daisuke Takayanagi
    • Daiki Nemoto
    • Masato Aizawa
    • Kenichi Utano
    • Kazutomo Togashi
  • View Affiliations

  • Published online on: March 20, 2021     https://doi.org/10.3892/mco.2021.2269
  • Article Number: 107
  • Copyright: © Nemoto et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The neutrophil‑to‑lymphocyte ratio (NLR) has been reported to be an independent prognostic factor of unresectable advanced or metastatic colorectal cancer (uCRC). However, few studies have documented changes in NLR during chemotherapy. The current study analyzed whether a change in NLR during chemotherapy in patients with uCRC could be used as a prognostic biomarker. The present retrospective study enrolled 71 patients who received first‑line chemotherapy for uCRC between April 2012 and April 2019. The exclusion criteria were as follows: Acute infection or systemic inflammatory disease, duration of first‑line chemotherapy <3 months, curative resection after chemotherapy and treatment with granulocyte‑colony stimulating factor within 1 month. NLR, Lymphocyte‑to‑monocyte ratio (LMR), platelet‑to‑­lymphocyte ratio (PLR), lactate dehydrogenase, alkaline phosphatase (ALP), albumin, carcinoembryonic antigen (CEA) and carbohydrate antigen 19‑9 (CA19‑9) levels were calculated before chemotherapy and at 3 months after chemotherapy. Among these laboratory data, NLR, PLR, ALP, CEA and CA19‑9 levels were significantly decreased during chemotherapy. For Cox univariate analyses, these five data makers were divided into two groups: Decreased and increased (comparing before and at 3 months after chemotherapy). Only the change in NLR was significantly associated with overall survival (P=0.0002). Furthermore, the overall survival (P<0.0001) and progression‑free survival (P=0.0041) of patients with decreased NLR was increased compared with patients with increased NLR. The change in NLR from pre‑chemotherapy to 3 months following chemotherapy was determined to be a predictor of prognosis in patients with uCRC. The ability to predict prognosis at an early phase of chemotherapy may provide useful information for the selection of subsequent treatment and may improve the quality of patient life.
View Figures
View References

Related Articles

Journal Cover

May-2021
Volume 14 Issue 5

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nemoto T, Endo S, Isohata N, Takayanagi D, Nemoto D, Aizawa M, Utano K and Togashi K: Change in the neutrophil‑to‑lymphocyte ratio during chemotherapy may predict prognosis in patients with advanced or metastatic colorectal cancer. Mol Clin Oncol 14: 107, 2021
APA
Nemoto, T., Endo, S., Isohata, N., Takayanagi, D., Nemoto, D., Aizawa, M. ... Togashi, K. (2021). Change in the neutrophil‑to‑lymphocyte ratio during chemotherapy may predict prognosis in patients with advanced or metastatic colorectal cancer. Molecular and Clinical Oncology, 14, 107. https://doi.org/10.3892/mco.2021.2269
MLA
Nemoto, T., Endo, S., Isohata, N., Takayanagi, D., Nemoto, D., Aizawa, M., Utano, K., Togashi, K."Change in the neutrophil‑to‑lymphocyte ratio during chemotherapy may predict prognosis in patients with advanced or metastatic colorectal cancer". Molecular and Clinical Oncology 14.5 (2021): 107.
Chicago
Nemoto, T., Endo, S., Isohata, N., Takayanagi, D., Nemoto, D., Aizawa, M., Utano, K., Togashi, K."Change in the neutrophil‑to‑lymphocyte ratio during chemotherapy may predict prognosis in patients with advanced or metastatic colorectal cancer". Molecular and Clinical Oncology 14, no. 5 (2021): 107. https://doi.org/10.3892/mco.2021.2269